Aminosalicylic acid resin complex - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for aminosalicylic acid resin complex and what is the scope of freedom to operate?
Aminosalicylic acid resin complex
is the generic ingredient in one branded drug marketed by Bristol Myers Squibb and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for aminosalicylic acid resin complex
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 149 |
| Clinical Trials: | 28 |
| DailyMed Link: | aminosalicylic acid resin complex at DailyMed |
Recent Clinical Trials for aminosalicylic acid resin complex
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | Early Phase 1 |
| Assistance Publique - Hôpitaux de Paris | Phase 1/Phase 2 |
| St George's University of London, London, UK | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for aminosalicylic acid resin complex
US Patents and Regulatory Information for aminosalicylic acid resin complex
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | REZIPAS | aminosalicylic acid resin complex | POWDER;ORAL | 009052-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
